https://www.abdn.ac.uk/iahs/documents/2016_Newsletter.pdf
Arthritis Research UK: “The LIFT Trial – Lessening the Impact of Fatigue: Therapies for inflammatory rheumatic
diseases”. £750,000 June 2016 – May 2020.
Fatigue is pervasive, disabling and challenging to manage across all inflammatory rheumatic diseases (IRDs).
Primarily, we seek to advance the implementation of fatigue alleviating physical activity support programmes and
cognitive‐behavioural treatments within health services. The interventions will be delivered centrally, by either
telephone or Skype, with view to enhancing cost‐effectiveness. The conduct of such a pragmatic trial also
presents an unique opportunity to a) investigate the underlying mechanisms of fatigue in order to optimise
future interventions and b) identify the moderators of physical activity and cognitive‐behavioural therapy efficacy
so as to inform future stratified trials and patient triage pathways. This multi‐disciplinary trial brings together all
three IAHS themes as well as a number of international leaders in the field. If successful, it has the potential to
unlock widespread access to much needed therapies and will provide vital insights into this commonly neglected
patient priority.
Dr. Neil Basu (Chief Investigator)